These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029 [TBL] [Abstract][Full Text] [Related]
48. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841 [TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view. Loffeld RJ Neth J Med; 2005 Oct; 63(9):344-7. PubMed ID: 16244381 [TBL] [Abstract][Full Text] [Related]
50. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Willich SN; Nocon M; Kulig M; Jaspersen D; Labenz J; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P Aliment Pharmacol Ther; 2006 Feb; 23(3):371-6. PubMed ID: 16422996 [TBL] [Abstract][Full Text] [Related]
51. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? Dellon ES; Shaheen NJ J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837 [TBL] [Abstract][Full Text] [Related]
52. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Bredenoord AJ; Hemmink GJ; Smout AJ Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635 [TBL] [Abstract][Full Text] [Related]
53. Bleeding Barrett's ulcer as a complication of GERD [corrected] in physically and intellectually disabled children--report of two cases. Jarocka-Cyrta E; Wasilewska J; Sendrowski K; Kaczmarski M Adv Med Sci; 2007; 52 Suppl 1():218-20. PubMed ID: 18229670 [TBL] [Abstract][Full Text] [Related]
55. Pathogenetic links between colorectal neoplasia and Barrett's esophagus. Kountouras J; Zavos C; Chatzopoulos D Gastrointest Endosc; 2006 Aug; 64(2):298. PubMed ID: 16860098 [No Abstract] [Full Text] [Related]
56. [The role of esophageal manometry in the management of the patients with gastro-esophageal reflux disease and Barrett's esophagus]. Hoară P; Bîrlă R; Gîndea C; Constantin A; Panaitescu G; Iordan N; Constantinoiu S Chirurgia (Bucur); 2008; 103(4):407-12. PubMed ID: 18780613 [TBL] [Abstract][Full Text] [Related]
57. Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence: Reply From Authors. Wang Z; Thrift AP Am J Gastroenterol; 2018 Nov; 113(11):1724-1725. PubMed ID: 30333530 [No Abstract] [Full Text] [Related]
58. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
59. [Prevalence of a pathological DGER (duodeno-gastric-oesophageal reflux) in patients with clinical symptoms of reflux disease]. Kunsch S; Linhart T; Fensterer H; Adler G; Gress TM; Ellenrieder V Z Gastroenterol; 2008 May; 46(5):409-14. PubMed ID: 18428099 [TBL] [Abstract][Full Text] [Related]
60. What is the clinical significance of stromal angiogenesis in Barrett's esophagus? Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]